Cancer immunotherapy of Wilms tumor: a narrative review.

Wilms tumor (WT) is the most common malignant tumor of the urinary system in children. Though the traditional treatment of surgery plus radiotherapy and chemotherapy achieves exciting clinical efficacy, in relapsed and refractory cases, the long-term overall survival rates are poor. Besides, chemotherapy and radiation have serious long-term toxic side effects on children. Cancer immunotherapy is a new tumor therapy that works by activating the body's immune system to allow immune cells to kill tumor cells more efficiently. Currently, cancer immunotherapy has been tested in clinical trials or basic studies in WT. This article reviews the current status of clinical trials and basic research of cancer immunotherapy in WT to promote the application of cancer immunotherapy in WT patients.

Citation

Yu Lin He, Jin Yan Liu, Rahma Taher Almgrami, Ying Zhong Fan, Yi Zhang. Cancer immunotherapy of Wilms tumor: a narrative review. Future oncology (London, England). 2024;20(30):2293-2302

Mesh Tags

Substances

PMID: 39235074

search → result